2,4-Diamino-quinazolines as inhibitors of β-catenin/Tcf-4 pathway: Potential treatment for colorectal cancer

被引：63

作者：

Chen, Zecheng ^{[1
]}

Venkatesan, Aranapakam M. ^{[1
]}

Dehnhardt, Christoph M. ^{[1
]}

Dos Santos, Osvaldo ^{[1
]}

Delos Santos, Efren ^{[1
]}

Ayral-Kaloustian, Semiramis ^{[1
]}

Chen, Lei ^{[2
]}

Geng, Yi ^{[2
]}

Arndt, Kim T. ^{[2
]}

Lucas, Judy ^{[2
]}

Chaudhary, Inder ^{[3
]}

Mansour, Tarek S. ^{[1
]}

机构：

[1] Wyeth Res, Chem Sci, Pearl River, NY 10965 USA

[2] Wyeth Res, Oncol, Pearl River, NY 10965 USA

[3] Wyeth Res, Drug Metab, Pearl River, NY 10965 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2009年 / 19卷 / 17期

关键词：

beta-Catenin/Tcf-4; pathway; Inhibitors; 2,4-Diamino-quinazoline; WNT; AXIN2; APC;

D O I：

10.1016/j.bmcl.2009.07.070

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The synthesis and SAR of a series of 2,4-diamino-quinazoline derivatives as beta-catenin/Tcf-4 inhibitors are described. This series was developed by modifying the initial lead 1, which was identified by screening of our compound library and found to inhibit the beta-catenin/Tcf-4 pathway. Replacement of the biphenyl moiety in compound 1 with the N-phenylpiperidine-4-carboxamide chain as in 2, resulted in a number of new analogues, which are potent inhibitors of the beta-catenin/Tcf-4 pathway. Compound such as 16k exhibited good cellular potency, solubility, metabolic stability and oral bioavailability. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：4980 / 4983

页数：4

共 39 条

[1] The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells
van de Wetering, M
Sancho, E
Verweij, C
de Lau, W
Oving, I
Hurlstone, A
van der Horn, K
Batlle, E
Coudreuse, D
Haramis, AP
Tion-Pon-Fong, M
Moerer, P
van den Born, M
Soete, G
Pals, S
Eilers, M
Medema, R
Clevers, H
CELL, 2002, 111 (02) : 241 - 250
[2] The Wnt/β-catenin/TCF-4 pathway upregulates HMGA1 expression in colon cancer
Sumter, Takita Felder
Bush, Bethany
Brock, Ashton
Deng, Jiayue
Nelson, Ronald
FASEB JOURNAL, 2013, 27
[3] Effects of gastrin 17 on β-catenin/Tcf-4 pathway in Colo320WT colon cancer cells
Jun Cao
World Journal of Gastroenterology, 2006, (46) : 7482 - 7487
[4] Effects of gastrin 17 on β-catenin/Tcf-4 pathway in Colo320WT colon cancer cells
Cao, Jun
Yu, Lie-Ping
Liu, Chao-Hong
Zhou, Lan
Yu, Hong-Gang
WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (46) : 7482 - 7487
[5] The β-Catenin/Tcf-4 Pathway Regulates High Mobility Group A1 (hmga1) Expression in Colorectal Cancers
Deng, Jiayue Amy
Brock, Ashton T.
Bush, Bethany M.
Sumter, Takita Felder
FASEB JOURNAL, 2012, 26
[6] Fast is a β-catenin/TCF-4 target gene repressed by Smads in RKO-1 colorectal cancer cells.
Chinery, R
Weller, SG
GASTROENTEROLOGY, 2001, 120 (05) : A46 - A46
[7] Transactivation of MCP-1/CCL2 by β-catenin/TCF-4 in human breast cancer cells
Mestdagt, M
Polette, M
Buttice, G
Noël, A
Ueda, A
Foidart, JM
Gilles, C
INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (01) : 35 - 42
[8] Human telomerase reverse transcriptase recruits the β-catenin/TCF-4 complex to transactivate chemokine (C-C motif) ligand 2 expression in colorectal cancer
Chen, Siyuan
Yang, Li
Dong, Hui
Guo, Hong
BIOMEDICINE & PHARMACOTHERAPY, 2019, 112
[9] Therapeutic Potential of Targeting Wnt/-Catenin Pathway in Treatment of Colorectal Cancer: Rational and Progress
Bahrami, Afsane
Amerizadeh, Forouzan
ShahidSales, Soodabeh
Khazaei, Majid
Ghayour-Mobarhan, Majid
Sadeghnia, Hamid Reza
Maftouh, Mina
Hassanian, Seyed Mahdi
Avan, Amir
JOURNAL OF CELLULAR BIOCHEMISTRY, 2017, 118 (08) : 1979 - 1983
[10] SATB2/β-catenin/TCF-LEF pathway induces cellular transformation by generating cancer stem cells in colorectal cancer
Wei Yu
Yiming Ma
Sharmila Shankar
Rakesh K. Srivastava
Scientific Reports, 7

← 1 2 3 4 →